Translating Research Into Practice

Effects of Aspirin on Colorectal Cancer Related to Lynch Syndrome

Sarah Leilani Beck, MS, FNP-BC, PCNP

From Binghamton Gastroenterology Associates, Binghamton, New York

The author has no conflicts of interest to disclose.

Correspondence to: Sarah Leilani Beck, MS, FNP-BC, PCNP, Binghamton Gastroenterology Associates, 40 Mitchell Avenue, 3rd floor, Binghamton, NY 13903. E-mail: ssilvanic@stny.rr.com


J Adv Pract Oncol 2012;3:395–398 | DOI: 10.6004/jadpro.2012.3.6.6 | © 2012 Harborside Press®


  

ABSTRACT

This article is a review of “Long-term effects of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial” by Burn et al. (2011), Lancet, 378, 2081–2087. For another perspective on the Burn et al. article as well as a discussion of challenges faced when interpreting a large prospective trial, please see the related article by Rita Wickham.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2021 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.